Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2835045
Reference Type
Journal Article
Title
Dopamine and serotonin regulate tumor behavior by affecting angiogenesis
Author(s)
Peters, MAM; Walenkamp, AME; Kema, IdoP; Meijer, C; de Vries, EGE; Oosting, SF
Year
2014
Is Peer Reviewed?
Yes
Journal
Drug Resistance Updates
ISSN:
1368-7646
Volume
17
Issue
4-6
Page Numbers
96-104
PMID
25269824
DOI
10.1016/j.drup.2014.09.001
Web of Science Id
WOS:000348016100003
Abstract
The biogenic amines dopamine and serotonin are neurotransmitters and hormones, which are mainly produced in the central nervous system and in the gastro-intestinal tract. They execute local and systemic functions such as intestinal motility and tissue repair. Dopamine and serotonin are primarily stored in and transported by platelets. This review focuses on the recently recognized role of dopamine and serotonin in the regulation of tumor behavior by affecting angiogenesis and tumor cell proliferation. Preclinical studies demonstrate that dopamine inhibits tumor growth via activation of dopamine receptor D2 on endothelial and tumor cells. Serotonin stimulates tumor growth via activation of serotonin receptor 2B on endothelial cells and serotonin receptors on tumor cells. Drugs that stimulate dopamine receptor D2 or inhibit serotonin receptors are available and therefore clinical intervention studies for cancer patients are within reach. (C) 2014 Elsevier Ltd. All rights reserved.
Keywords
Dopamine; Serotonin; Biogenic amines; Angiogenesis; Cancer
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity